【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 17
1.2 List of Figures 22
2 Introduction 24
2.1 Catalyst 24
2.2 Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 26
3.1.1 Etiology 26
3.1.2 Pathophysiology 29
3.2 Symptoms 41
4 Epidemiology 43
4.1 Risk Factors and Comorbidities 43
4.1.1 Family history of Alzheimer’s disease increases the risk by 7.5 times 44
4.1.2 APOE ε4 allele triples the risk of Alzheimer’s disease 44
4.1.3 Cardiovascular risk factors increase the risk of Alzheimer’s disease by twofold 44
4.1.4 Incidence and prevalence of Alzheimer’s disease double every five years after age 65 45
4.1.5 Diabetes doubles the risk of Alzheimer’s in men, but only marginally increases the risk in women 45
4.1.6 Women are 1.5 times more likely to develop Alzheimer’s disease than men 46
4.1.7 Mild cognitive impairment increases the risk of Alzheimer’s disease, but may be part of the causal pathway 46
4.1.8 Depression triples the risk of Alzheimer’s disease and is the most common comorbidity 47
4.1.9 Up to 70% of Alzheimer’s disease patients also suffer from anxiety 47
4.1.10 Psychosis and agitation are common comorbidities among Alzheimer’s patients 48
4.2 Global and Historical Trends 48
4.2.1 United States 49
4.2.2 5EU 49
4.2.3 Japan 50
4.2.4 China 50
4.2.5 India 50
4.3 Forecast Methodology 51
4.3.1 Sources Used 53
4.3.2 Forecast Assumptions and Methods 56
4.3.3 Sources Not Used 58
4.4 Epidemiology Forecast (2012-2022) 59
4.4.1 Prevalent Cases of Alzheimer’s Disease 59
4.4.2 Age-Specific Prevalent Cases of Alzheimer’s Disease 60
4.4.3 Sex-Specific Prevalent Cases of Alzheimer’s Disease 62
4.4.4 Age-Standardized Prevalence of Alzheimer’s Disease 63
4.5 Discussion 65
4.5.1 Conclusions Regarding Epidemiological Trends 65
4.5.2 Limitations of the Analysis 67
4.5.3 Strengths of the Analysis 67
5 Disease Management 68
5.1 Diagnosis 68
5.1.1 Probable Alzheimer’s Disease Dementia 69
5.1.2 Possible AD Dementia 70
5.1.3 Probable AD Dementia with Evidence of AD Pathophysiological Process 70
5.1.4 Possible Alzheimer’s Dementia with Evidence of the Alzheimer’s Disease Pathophysiological Process 71
5.1.5 Preclinical AD 71
5.1.6 Mild Cognitive Impairment 72
5.2 Treatment Overview 74
5.3 United States 77
5.3.1 Diagnosis 77
5.3.2 Clinical Practice 77
5.4 France 79
5.4.1 Diagnosis 79
5.4.2 Clinical Practice 79
5.5 Germany 81
5.5.1 Diagnosis 81
5.5.2 Clinical Practice 81
5.6 Italy 82
5.6.1 Diagnosis 82
5.6.2 Clinical Practice 82
5.7 Spain 84
5.7.1 Diagnosis 84
5.7.2 Clinical Practice 84
5.8 UK 85
5.8.1 Diagnosis 85
5.8.2 Clinical Practice 86
5.9 Japan 87
5.9.1 Diagnosis 87
5.9.2 Clinical Practice 88
5.10 China 90
5.10.1 Diagnosis 90
5.10.2 Clinical Practice 90
5.11 India 92
5.11.1 Diagnosis 92
5.11.2 Clinical Practice 92
6 Competitive Assessment 95
6.1 Overview 95
6.2 Strategic Competitor Assessment 95
6.3 Product Profiles – Major Brands 97
6.3.1 Aricept (donepezil hydrochloride) 97
6.3.2 Exelon (rivastigmine, rivastigmine tartrate) 103
6.3.3 Razadyne (galantamine hydrobromide) 108
6.3.4 Namenda (memantine hydrochloride) 113
7 Opportunity and Unmet Need 118
7.1 Unmet Needs Overview 118
7.1.1 Public Awareness 120
7.1.2 Specialized Institutions at Local Levels 121
7.1.3 Screening and Diagnosis 121
7.1.4 Early Intervention 122
7.1.5 Improved Clinical Trial Design 123
7.1.6 Effective Therapy 124
7.1.7 Behavioral Treatments 125
7.2 Gap Analysis 125
7.2.1 Disease Prevention 126
7.2.2 Diagnosis from Biomarkers 127
7.2.3 Behavioral Therapies 128
8 Pipeline Assessment 129
8.1 Overview 129
8.2 Clinical Trial Mapping 129
8.2.1 Clinical Trials by Country 129
8.3 Clinical Trials by Phase and Trial Status 130
8.4 Early-Stage Pipeline Assessment 133
8.5 AD Pipeline by Mechanism of Action 135
8.6 Enzymatic Processing 135
8.7 Immunization 136
8.8 Anti-Aggregation 137
8.9 “Me-Too” 137
8.10 Novel Therapeutic Approaches 138
8.11 Technology Trends Analytic Framework 139
8.12 Promising Drugs in Clinical Development 140
8.12.1 Namenda XR 141
8.12.2 Arimenda 145
8.12.3 Gammagard Liquid 10% 148
8.12.4 Solanezumab 150
8.12.5 Gantenerumab 154
8.12.6 Crenezumab 160
8.12.7 TRx0237 164
8.12.8 MK-8931 168
8.12.9 EVP-6124 172
8.12.10 Lu AE58054 176
9 Current and Future Players 180
9.1 Overview 180
9.2 Trends in Corporate Strategy 181
9.3 Company Profiles 183
9.3.1 GlaxoSmithKline 183
9.3.2 F. Hoffman-La Roche (Roche) 186
9.3.3 Pfizer 189
9.3.4 Novartis 192
9.3.5 AbbVie (Abbott Laboratories) 195
9.3.6 Lundbeck 197
9.3.7 Eli Lilly 200
9.3.8 Baxter International 204
9.3.9 EnVivo Pharmaceuticals 206
9.3.10 Adamas Pharmaceuticals 209
9.3.11 Johnson & Johnson 210
10 Market Outlook 213
10.1 Global Markets 213
10.1.1 Forecast 213
10.1.2 Global Drivers and Barriers 217
10.1.3 Alternative Scenarios 221
10.2 United States 224
10.2.1 Forecast 224
10.2.2 Key Events 228
10.2.3 Drivers and Barriers 228
10.3 France 232
10.3.1 Forecast 232
10.3.2 Key Events 236
10.3.3 Drivers and Barriers 236
10.4 Germany 240
10.4.1 Forecast 240
10.4.2 Key Events 243
10.4.3 Drivers and Barriers 243
10.5 Italy 246
10.5.1 Forecast 246
10.5.2 Key Events 249
10.5.3 Drivers and Barriers 249
10.6 Spain 251
10.6.1 Forecast 251
10.6.2 Key Events 254
10.6.3 Drivers and Barriers 254
10.7 United Kingdom 256
10.7.1 Forecast 256
10.7.2 Key Events 259
10.7.3 Drivers and Barriers 259
10.8 Japan 263
10.8.1 Forecast 263
10.8.2 Key Events 266
10.8.3 Drivers and Barriers 266
10.9 China 268
10.9.1 Forecast 268
10.9.2 Key Events 272
10.9.3 Drivers and Barriers 272
10.10 India 274
10.10.1 Forecast 274
10.10.2 Key Events 276
10.10.3 Drivers and Barriers 276
11 Appendix 279
11.1 Bibliography 279
11.2 Abbreviations 297
11.3 Methodology 304
11.4 Forecasting Methodology 304
11.4.1 Diagnosed AD patients 305
11.4.2 Percent Drug-treated Patients 306
11.4.3 Drugs Included in Each Therapeutic Class 306
11.4.4 Launch and Patent Expiry Dates 307
11.4.5 General Pricing Assumptions 308
11.4.6 Individual Drug Assumptions 310
11.4.7 Generic Erosion 316
11.4.8 Pricing of Pipeline Agents 316
11.4.9 Alternate Scenarios 317
11.5 Physicians and Specialists Included in this Study 318
11.6 About the Authors 319
11.6.1 Author 319
11.6.2 Epidemiology 319
11.6.3 Global Head of Healthcare 323
11.7 About GlobalData 324
11.8 Disclaimer 324
【レポート販売概要】
■ タイトル：アルツハイマー型認知症：世界市場（医薬品市場予測及び分析～2022）■ 英文：PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2022
■ 発行日：2013年7月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161526
■ 調査対象地域：グローバル
- 血液培養試験の世界市場分析：製品別（消耗品、機器）、技術別（培養技術）、用途別、方法別、エンドユーザー別、セグメント予測、2014-2025The global blood culture tests market is expected to reach USD 6.6 billion by the year 2025, according to a new report by Grand View Research, Inc. The increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the market growth during the forecast period. Increasing demand for advanced diagnostic techniques for the diagnosis of inf …
- 世界の殺鼠剤市場2015The Global Rodenticides Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Rodenticides industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Rodenticides market analysis is provided for the international markets including development trends, competitive …
- MEMS磁気センサの世界市場2016-2020About MEMS Magnetic Sensors A sensor measures or responds to physical changes in its environment and transforms mechanical signals into electric signals. Magnetic sensors use magnetic fields to sense changes in speed, motion, and direction. MEMS-based magnetic sensors are small devices used for measuring and detecting magnetic fields. Most of these devices function by detecting Lorentz force effec …
- 世界の抗菌性コーティング市場動向と予測The Antimicrobial Coatings report covers the major antimicrobials that are used to prevent or inactivate microbes, such as bacteria, fungi (including molds), and viruses. The major additives considered in this report are Silver, Copper, Zinc oxide, Zirconium, Titanium dioxide, and Zinc omadine. The market is divided further on the basis of their major applications such as Indoor air/HVAC, Medical, …
- 自動車用クーラントの世界市場：有機酸、無機酸、有機酸混合タイプAbout automotive coolants Automotive coolants form an integral part of vehicles and are used in the engines and HVAC systems of the automobiles. They are used to prevent freezing and heating, and provides protection from corrosion. Generally, most of the automotive coolants are made of ethylene glycol, but due to high toxicity of the ethylene glycol, automotive manufacturers are shifting their pre …
- Lucas Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析– 2012Lucas Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Lucas Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 世界のモノのインターネット(IoT) 及びM2M通信市場動向及び予測(2014 – 2019)Internet of Things (IoT) and Machine-to-Machine (M2M) communication are the essence of the smart productivity and living. IoT and M2M is a worldwide network of interconnected objects. With full of dynamicity, the objects can interact anywhere and anytime and can interoperate and collaborate heterogeneous range of entities. It is expected that by 2025 a trillion of interconnected devices will be pr …
- 産業用Vベルトの世界市場2017-2021ABSTRACTAbout Industrial V-Belts Industrial V-belts are the basic belts for power transmission that is applied in light-weight to heavy-weight industrial applications. They are used as a source to provide power transmission efficiently. Industrial V-belts provide more friction and power and are installed in all end-user orientations for efficient machinery functions. Industrial V-belts are an inte …
- 口腔がん治療法の世界市場2019-2023Global Oral Cancer Therapeutics Market: About this market Technavio’s oral cancer therapeutics market analysis considers sales from both targeted therapy and chemotherapy. Our analysis also considers the sales of oral cancer therapeutics in Asia, Europe, North America, and ROW. In 2018, the targeted therapy segment had a significant market share, and this trend is expected to continue over the for …
- 自動車向けクラウド基盤ソリューションの世界市場予測（～2022年）：フリート管理、インフォテインメント、OTAアップデート、テレマティクス、ADAS“Demand for integration of smartphones with vehicles is driving the market for cloud based solutions market for automotive”The global cloud based solutions market for automotive is estimated to be USD 27.03 billion in 2017 and is projected to reach USD 66.95 billion by 2022, at a CAGR of 19.88%. The growing demand for upgraded infotainment systems, in-car connectivity etc. is expected to increase …
- 眼科疾患治療薬の世界市場：緑内障、眼球乾燥症候群、網膜障害（糖尿病性網膜症、黄斑浮腫、RVO、AMD）About Ophthalmic Diseases Ophthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms at early stages. They will be painless with no defect in vi …
- 生物学的製剤API（原薬）製造サービスの世界市場予測2016-2026Biological Drug API Manufacturing Services World Industry and Market Predictions 2016-2026: Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine reviews the contract active pharmaceutical ingredient (API) manufacturing market for biologics. This study gives quantitative and qualitative analysis for that overall world market, as …
- 非破壊検査（NDT）の世界市場：目視試験、磁粉探傷試験、浸透探傷試験、渦電流探傷試験、超音波探傷試験、放射線透過試験、アコースティック・エミッション、テラヘルツイメージングThe non-destructive testing (NDT) market is expected to reach USD 11.39 Billion by 2022 at a CAGR of 8.30% between 2016 and 2022. NDT assures safety and reliability by identifying flaws and defects in products without disrupting operations or delaying processes. Non-destructive testing has its applications in various industries such as aerospace & defense, automotive, oil & gas, infrastructure, an …
- 産業制御/FA（ファクトリーオートメーション）の世界市場予測The convergence of the physical and the virtual worlds through Cyber-Physical-Systems (CPS), and the consequent fusion of business processes and technical processes have set the pace of the industrial control and factory automation concept. Industrial Control and Factory Automation brings lot of advantages such as improved efficiency and reduced costs compared to conventional manufacturing process …
- アジア太平洋の物流サービス市場2016-2020About Logistics Market in the APAC Region Logistics is an important element of supply chain management (SCM). It includes the transportation, storage, and distribution of goods from the point of origin to the destination. Customers outsource their logistics and transportation functions to service providers that specialize in handling logistics functions like freight and forwarding, transportation, …
